This Roche business report presents the course of business throughout the respective business year. The 2023 report complies with the disclosure requirement for corporate entities and generally includes the balance sheet, the annual statement of the comp
annual reporting.Roche is committed to transparent reporting and we endeavour to drive our economic,social and environmental perance with the same diligence as our financial perance.Reporting scope and boundariesOur financial and non-financial reporting consists of the Annual Report,the Finance Report ...
Part 1 Business ReportWe Innovate HealthcareRoche Business Report SurveyThe Annual Report informs you about Roche's financial and operating results in 2006, as well asthe company's strategic direction for the longer term.Because we value your opinion as a reader of our reports, we want to find...
We may share your Personal Data with Roche’s affiliates around the world. Our Roche affiliates will use your Personal Data for the same purposes as we do. A list of Roche’s affiliates is available in the current annual report, which can be found in the Investors section of We may also...
This Roche business report presents the course of business throughout the respective business year. The 2023 report complies with the disclosure requirement for corporate entities and generally includes the balance sheet, the annual statement of the comp
The article reports that Sanofi-Aventis SA, Roche and Novartis AG in leading the European Commission's annual industrial research and development scoreboard.EBSCO_bspManufacturing Chemist
“Risk Factors” section of Poseida’s Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent Quarterly Reports on Form 10-Q, Form 8-K and in other filings Poseida makes with the SEC ...
Health protection response to reports of hepatitis E infection. 2019 Guidelines; 2Webb GW, Dalton HR. Hepatitis E: an underestimated emerging threat. Ther Adv Infect Dis. 2019;6:1-18; 3The selection and use of essential in vitro diagnostics: report of the fourth meeting of the WHO Strategic...
Detailed information on dividend history can be found on the Financial Reports page Contact us How do I contact investor relations in the U.S.? Please contact the Investor Relations Team via email: This website contains information on products which is targeted to a wide range of audiences and...
Pharma Insight Reports New Contact Us Help Login Username/Password Institution access Request demo MENU Search Drug Profile Zinpentraxin alfa - Roche Alternative Names: PRM-151; recombinant human pentraxin-2 - Roche; RG-6354; rhPentraxin-2; rhPTX 2; rhSAP; RO-7490677 Latest ...